Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
22:20:38 EDT Thu 18 Apr 2024
Enter Symbol
or Name
USA
CA



Z:IGC - IGC PHARMA INC - http://www.indiaglobalcap.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
IGC - Z0.10.4307·0.52640.10.4761-0.1134-19.21,360.66291,6230.5661  0.57  0.470.9099  0.250119:54:17Apr 1615 min RT 2¢

Recent Trades - Last 10 of 1623
Time ETExPriceChangeVolume
19:54:17Z0.489-0.09752
19:47:33Z0.4998-0.0867200
19:43:27Z0.4999-0.086650
19:42:53Z0.4709-0.115610
19:39:18Z0.4872-0.09935
19:38:01Z0.4999-0.08663
19:34:08Z0.472-0.11458
19:33:56Z0.4999-0.086650
19:26:52Z0.4999-0.08661
19:26:39Z0.4709-0.11564

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-04-16 07:00U:IGCNews ReleaseIGC-AD1's Interim Phase 2 Data Show a Reduction in Alzheimer's Agitation at Week Two
2024-04-09 09:00U:IGCNews ReleaseIGC Pharma Adds Advisor in Artificial Intelligence
2024-03-26 15:00U:IGCNews ReleaseIGC Pharma Announces $3 Million Unregistered Private Placement of its Common Stock
2024-03-20 11:00U:IGCNews ReleaseIGC Pharma Announces Positive Interim Results for IGC-AD1 in Reducing Alzheimer's Agitation
2024-03-20 07:00U:IGCNews ReleaseIGC PHARMA Announces its Participation at the Benzinga Virtual Healthcare Summit 2024
2024-03-12 15:00U:IGCNews ReleaseIGC Pharma (IGC): Healthcare Leader Terry Lierman Joins Board to Advance Alzheimer's Pipeline
2024-02-28 13:00U:IGCNews ReleasePromising Results: TGR-63 Enhances Memory in Alzheimer's Mouse Model
2024-02-23 12:01U:IGCNews ReleaseIGC Pharma Announces Equity Analyst Coverage by Ascendiant with a "Buy" Recommendation and $3.00 Price Target
2024-02-16 19:05U:IGCNews ReleaseIGC Pharma Reports Third Quarter Fiscal 2024 Results
2024-02-01 09:20U:IGCNews ReleaseIGC Pharma Announces TGR-63 Reduces Agitation in Alzheimer's Mouse Model
2024-01-23 09:20U:IGCNews ReleaseIGC Pharma Breakthrough: Preclinical Trial Data Shows TGR-63 Reduces Plaque in Alzheimer ¢ € ™s
2024-01-17 09:20U:IGCNews ReleaseIGC Pharma Activates ClinCloud, One of 12 Sites in Ongoing Phase 2b Alzheimer ¢ € ™s Trial
2023-12-19 09:20U:IGCNews ReleasePatent Granted to IGC Pharma for Groundbreaking Drug Formulation to Treat Agitation in Alzheimer ¢ € ™s
2023-12-13 09:30U:IGCNews ReleaseIGC Pharma Announces Participation in Biotech Showcase and BioPartnering @ JPM Alongside the J.P. Morgan 41st Annual Healthcare Conference 2024
2023-12-06 08:30U:IGCNews ReleaseIGC Pharma Announces Collaboration to Integrate AI into Clinical Trials
2023-11-21 08:30U:IGCNews ReleaseIGC Pharma Announces Master Agreement with Leading South American University to Advance AI Initiatives
2023-11-13 08:00U:IGCNews ReleaseIGC Pharma Reports Second Quarter Fiscal 2024 Results
2023-10-19 15:30U:IGCNews ReleaseIGC Pharma Granted European Patent for Groundbreaking Cannabinoid-Based Pain Topical Relief Therapy
2023-08-21 14:30U:IGCNews ReleaseIGC Announces Results of its 2023 Annual Stockholders Meeting
2023-08-14 08:30U:IGCNews ReleaseIGC Pharma Reports First Quarter Results; Company Continues to Make Significant Progress Advancing Its Lead Alzheimer ¢ € ™s Candidate Through Phase 2 Clinical Trials